Blood stem cells develop through different stages to become fully mature red blood cells. This fundamental biologic process ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

The study in Cell highlights microbial load's role in gut microbiome variation, suggesting it as a confounder in disease ...

2 NIHR Biomedical Research Centre at Guy's and Saint Thomas' NHS Foundation Trust and King's College, London, UK The prevalence of IBD is rising in the Western world. Despite an increasing repertoire ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...

Scientists have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal samples that are recognized by IgA antibodies. These 'IgA-coated' bacteria are associated ...

2-Year U.S. Treasury Note Continuous Contract $102.590-0.086-0.08% 5-Year U.S. Treasury Note Continuous Contract $106.445-0.156-0.15% 10-Year U.S. Treasury Note Continuous Contract $109.344-0.203 ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...